Skip to content
Indrayani Biotech logo

Indrayani Biotech

526445 BSE
₹8.00

Close ·

P/E
36.36
View as Markdown
MCP
Close 4 Nov 2026 ₹8.00 −7.66 −48.9% 1Y
Start ₹15.66

Key Fundamentals

MicrocapConsumer GoodsFMCG

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
4.24%
Debt to Equity
1.75
EPS (TTM)
₹0.22
Book Value
₹15.59
Market Cap
—
P/E (TTM)
36.36
P/B
0.51
ROE
2.97%
Dividend Yield
0.00%
EBITDA
₹9.63 Cr
52W High
₹16.47
52W Low
₹6.10

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

48 Average

Data confidence 100/100

Category scores

Quality
73
Strong
Returns, margins, earnings quality 22% weight
Valuation
47
Average
Cheap vs sector & own history 24% weight
Growth
46
Average
Sales & profit trajectory 9% weight
Financial Health
21
Poor
Solvency, leverage, coverage 9% weight
Momentum
26
Poor
Trend strength, vol-adjusted 12% weight
Ownership
46
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 1.08 times its book value

Weaknesses

7
  • Company has low interest coverage ratio.
  • Promoter holding is low: 32.9%
  • Company has a low return on equity of 1.21% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.4.57 Cr.
  • Company has high debtors of 155 days.
  • Promoter holding has decreased over last 3 years: -11.9%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1270
OscillatorsBearish270
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
43.26
Neutral
MACD (12,26,9)
−0.36
Bearish
SMA (50)
8.85
Bearish
SMA (200)
9.20
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
10YIrregular period
5Y+45.72%
3Y−5.40%
1Y+6.15%

Net profit

Net profit growth by window
10YIrregular period
5YTurned to profit
3Y−44.97%
1YTurned to profit

Operating cash flow

Operating cash flow growth by window
10YIrregular period
5YZero base
3Y+25.99%
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
10YIrregular period
5Y+31.06 pp
3Y−3.18 pp
1Y+2.63 pp

Trailing twelve months: The last four quarters end with the latest fiscal year, which the 1Y column covers.

Revenue by year

Revenue by year, ₹ crore
Mar 2010₹0.00 Cr
Mar 2011₹39.00 Cr
Mar 2012₹58.00 Cr
Mar 2020₹50.00 Cr
Mar 2021₹21.00 Cr
Mar 2022₹61.00 Cr
Mar 2023₹163 Cr
Mar 2024₹165 Cr
Mar 2025₹130 Cr
Mar 2026₹138 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2010₹0.00 Cr
Mar 2011₹0.00 Cr
Mar 2012₹0.00 Cr
Mar 2020₹1.00 Cr
Mar 2021−₹11.00 Cr
Mar 2022₹4.00 Cr
Mar 2023₹12.00 Cr
Mar 2024₹10.00 Cr
Mar 2025−₹6.00 Cr
Mar 2026₹2.00 Cr

Quarterly Results

₹ Cr

Results for the period ended Jun 2026 were due by 14 Aug 2026 and are not in this table yet.

526445 quarterly results, ₹ crore
Particulars Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
49.25
42.31
40.44
39.09
44.38
31.53
30.81
17.32
50.57
29.1
35.95
35.01
37.76
Expenses
46.07
39.77
33.15
35.64
34.21
25.55
25.7
14.4
56.31
26.92
33.5
32.22
35.54
Operating Profit
3.18
2.54
7.29
3.45
10.17
5.98
5.11
2.92
−5.74
2.18
2.45
2.79
2.22
OPM %
6.46%
6%
18.03%
8.83%
22.92%
18.97%
16.59%
16.86%
−11.35%
7.49%
6.82%
7.97%
5.88%
Other Income
2.05
0.01
0.09
0.08
1.03
0.04
0.3
0
2.78
1.06
1.8
0.83
0.88
Interest
2.23
2.03
0.93
1.41
5.51
0.83
1.42
1.03
7.07
2.17
1.89
2.47
3.08
Depreciation
1.15
0.9
0.91
1.03
0.96
4.25
2.79
1.46
−1.72
0.86
1.3
1.01
1.13
PBT
1.85
−0.38
5.54
1.09
4.73
0.94
1.2
0.43
−8.31
0.21
1.06
0.14
−1.11
Tax %
21.62%
15.79%
0%
0%
0%
9.57%
−1.67%
18.6%
2.53%
23.81%
14.15%
21.43%
−187.39%
Net Profit
1.44
−0.45
5.54
1.08
4.73
0.85
1.22
0.35
−8.53
0.16
0.91
0.12
0.98
EPS (₹)
0.18
−0.08
0.94
0.13
0.5
0.11
0.16
0.03
−1.09
0.02
0.05
0.02
0.13

Profit & Loss

₹ Cr
526445 profit and loss, annual, ₹ crore
Particulars Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
0
39
58
50
21
61
163
165
130
138
Expenses
0
39
57
47
26
54
145
142
124
128
Operating Profit
0
1
1
3
−5
7
17
24
6
10
OPM %
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
1.9%
0.9%
6%
−24%
11%
11%
14%
4.9%
7%
Other Income
0
0
0
0
−4
0
4
1
3
5
Interest
0
0
0
1
2
2
6
10
12
10
Depreciation
0
0
0
1
0
1
3
4
3
4
PBT
0
0
0
1
−11
4
12
11
−6
0
Tax %
0%
150%
300%
0%
0%
0%
3%
5%
6%
−620%
Net Profit
0
0
0
1
−11
4
12
10
−6
2
EPS (₹)
—
−0.08
−0.1
1.31
−1.91
0.76
1.49
0.81
−0.78
0.28
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
526445 balance sheet, annual, ₹ crore
Particulars Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6
4
4
4
34
34
34
46
46
46
Reserves
−6
0
0
27
−15
−10
12
22
27
27
Borrowings
0
0
0
14
16
19
79
113
137
128
Other Liabilities
1
6
9
7
5
8
31
54
58
52
Total Liabilities
1
10
12
51
40
51
156
234
268
253
Fixed Assets
1
6
6
17
15
17
57
62
58
60
CWIP
0
0
0
14
14
13
14
20
26
27
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
0
4
7
21
11
22
85
151
184
166
Total Assets
1
10
12
51
40
51
156
234
268
253

Cash Flow

₹ Cr
526445 cash flow, annual, ₹ crore
Particulars Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
1
2
6
0
4
16
−30
−7
32
Investing
—
−3
0
−4
−1
−1
−47
−16
25
−13
Financing
—
2
−1
−1
0
−3
33
44
−18
−15
Net Cash Flow
—
0
1
1
−1
1
2
−2
0
4
Free Cash Flow
—
−2
2
2
0
3
−25
−47
−8
23
CFO/OP
—
122
331
215
−5
61
94
−128
−124
328

Ratios

526445 financial ratios, annual
Particulars Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
26
26
52
84
84
67
87
165
155
Inventory Days
—
—
—
57
25
14
44
159
182
147
Days Payable
—
—
—
70
77
52
81
141
104
55
Cash Conversion Cycle
—
26
26
38
32
46
30
106
243
247
Working Capital Days
—
−22
−19
30
−59
−12
6
127
211
163
ROCE %
—
28%
12%
—
−13%
16%
23%
14%
3%
4%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Indrayani Biotech insights

58 extracted metrics across FY09–FY26.

Shareholding Pattern

As of Jun 2026

  • Public 49.48%
  • Promoters 32.92%
  • Others 14.47%
  • DIIs 3.13%

24.82% of promoter holding pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Indrayani Biotech

What does Indrayani Biotech Ltd do?
Incorporated in 1992, Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and Healthcare
Where is Indrayani Biotech Ltd (INDRANIB) listed?
Indrayani Biotech Ltd trades under code 526445 on the BSE.
Which sector does Indrayani Biotech Ltd belong to?
Indrayani Biotech Ltd is classified under the FMCG sector, in the Agricultural Products industry.
What is the PE ratio of Indrayani Biotech Ltd?
Indrayani Biotech Ltd trades at a PE ratio of 36.36 as of 4 Nov 2026, on earnings per share of ₹0.22, against a book value of ₹15.59 per share.
What is the 52-week high and low of Indrayani Biotech Ltd?
Over the last 52 weeks Indrayani Biotech Ltd has traded between ₹6.1 and ₹16.47 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Indrayani Biotech Ltd?
Indrayani Biotech Ltd reported a return on equity of 2.97%. Its debt-to-equity ratio is 1.75.

Company Information

Incorporated in 1992, Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and Healthcare

Website indrayani.com
Listed 14 Feb 1994
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526445.md for Indrayani Biotech Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Agri & Food Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month